Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.495 USD | +5.64% | -2.04% | +6.67% |
Apr. 19 | US FDA mandates label updates on CAR-T cancer therapies | RE |
Apr. 05 | Bristol-Myers Squibb, 2seventy Bio Say FDA Approves Expansion of Myeloma Treatment's Indication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.67% | 219M | |
+2.56% | 42.75B | |
+47.70% | 41.61B | |
+11.97% | 41.34B | |
-8.83% | 26.59B | |
+7.11% | 25.49B | |
-22.84% | 18.12B | |
+30.59% | 12.24B | |
-2.05% | 11.76B | |
+9.15% | 11B |
- Stock Market
- Equities
- TSVT Stock
- News 2seventy bio, Inc.
- Earnings Flash (TSVT) 2SEVENTY BIO Posts Q4 Revenue $10.7M, vs. Street Est of $15.2M